Zurcher Kantonalbank Zurich Cantonalbank Raises Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 24.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 187,398 shares of the medical equipment provider’s stock after purchasing an additional 36,865 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank owned 0.05% of Intuitive Surgical worth $97,814,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. M.E. Allison & CO. Inc. purchased a new position in shares of Intuitive Surgical during the fourth quarter worth about $449,000. Seilern Investment Management Ltd purchased a new position in shares of Intuitive Surgical during the fourth quarter worth about $82,517,000. Sycomore Asset Management grew its holdings in shares of Intuitive Surgical by 27.4% during the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after purchasing an additional 4,079 shares in the last quarter. Exome Asset Management LLC lifted its position in Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after buying an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. lifted its position in Intuitive Surgical by 5.6% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after buying an additional 525 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In related news, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares of the company’s stock, valued at $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Jamie Samath sold 94 shares of the company’s stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the sale, the chief financial officer now directly owns 2,630 shares in the company, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 13,579 shares of company stock valued at $7,756,844 over the last ninety days. Company insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the company. Royal Bank of Canada boosted their target price on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Bernstein Bank boosted their target price on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Piper Sandler restated an “overweight” rating and issued a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Finally, JPMorgan Chase & Co. boosted their target price on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Stock Down 3.8 %

Shares of ISRG stock opened at $518.26 on Monday. The stock has a market cap of $184.59 billion, a price-to-earnings ratio of 80.85, a PEG ratio of 5.85 and a beta of 1.43. The business’s fifty day moving average is $571.36 and its 200 day moving average is $531.85. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.